ADC Therapeutics
ADC Therapeutics's Overview
ADC Therapeutics SA (NYSE: ADCT) is a commercial-stage biotechnology company focused on significantly improving the lives of cancer patients through the development and commercialization of its next-generation antibody-drug conjugates (ADCs). The company's proprietary PBD-based ADC technology aims to deliver highly potent cancer-killing agents directly to tumor cells, minimizing toxicity to healthy tissues. Their lead product, ZYNLONTA® (loncastuximab tesirine-lpyl), is approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma. ADC Therapeutics has a robust pipeline of ADCs in various stages of clinical development for both hematological and solid tumors.
Where is ADC Therapeutics's Headquarters?
HQ Function
The Swiss headquarters serves as the central hub for global operations, including research and development leadership, corporate strategy, finance, and administrative functions.
Notable Features:
Located within Biopôle, a leading Swiss life sciences park, offering a collaborative environment with access to state-of-the-art infrastructure and a network of research institutions and biotech companies.
Work Culture:
The work culture is characterized by scientific rigor, innovation, and a strong patient-centric focus. It fosters collaboration among multidisciplinary teams dedicated to advancing cancer treatments.
HQ Significance:
Its location in a prominent European life sciences hub provides strategic advantages for talent acquisition, research collaborations, and international business development.
Values Reflected in HQ: The headquarters' placement in a dynamic innovation hub reflects the company's commitment to cutting-edge science, collaboration, and growth in the biopharmaceutical sector.
Location:
ADC Therapeutics operates with a global footprint, supporting functions such as research and development in Switzerland and the US (California), clinical operations across North America and Europe, and commercial activities primarily focused on the United States with plans for expansion. Manufacturing is managed through contract development and manufacturing organizations (CDMOs) globally.
Street Address:
Biopôle, Route de la Corniche 3
City:
Epalinges
State/Province:
Vaud
Country:
Switzerland
ADC Therapeutics's Global Presence
New Providence, New Jersey, USA
Address: 430 Mountain Ave, Suite 300, New Providence, NJ 07974, USA
To drive commercialization efforts for approved products like ZYNLONTA® in the U.S. market and manage clinical trials and regulatory submissions for the region.
London, United Kingdom
Address: The Harley Building, 77 New Cavendish Street, London, W1W 6XB, United Kingdom
To manage and support clinical trial execution, engage with European regulatory authorities and key opinion leaders, and prepare for potential market access in Europe.
San Mateo, California, USA
Address: Specific address not prominently listed, but presence noted for research/discovery.
To contribute to the early-stage pipeline development and innovation in ADC technology.
Buying Intent Signals for ADC Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of ADC Therapeutics
As of April 2025, ADC Therapeutics' leadership includes:
Investors of ADC Therapeutics
ADC Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
ADC Therapeutics has made strategic appointments to its executive team in the past year to bolster its commercial and financial leadership.
New Appointments:
Technology (Tech Stack) used by ADC Therapeutics
Discover the tools ADC Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ADC Therapeutics Email Formats and Examples
ADC Therapeutics commonly uses the [first].[last]@adctherapeutics.com email format for its employees. This is a standard pattern in many corporate environments.
[first].[last]@adctherapeutics.com
Format
john.doe@adctherapeutics.com
Example
90%
Success rate
News and media
ADC Therapeutics Website • May 9, 2024
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
ADC Therapeutics announced its financial results for Q1 2024, highlighting ZYNLONTA net sales of $19.0 million and progress in its clinical pipeline, including updated positive interim results from its LOTIS-7 trial....more
ADC Therapeutics Website • April 11, 2024
ADC Therapeutics Announces Updated Positive Interim Results from Pivotal Phase 2 LOTIS-5 Trial of ZYNLONTA® and Rituximab (R-lonca) in Unfit/Unsuitable Second-Line DLBCL Patients
The company shared positive interim data from its LOTIS-5 trial, showing promising efficacy and manageable safety for ZYNLONTA in combination with rituximab for certain DLBCL patients, with an oral presentation scheduled for ASCO 2024....more
ADC Therapeutics Website • March 12, 2024
ADC Therapeutics and Sobi Announce First Patient Dosed in Bridging Study with ZYNLONTA® (loncastuximab tesirine-lpyl) to Support Potential Future Regulatory Submission in China
In collaboration with Sobi, ADC Therapeutics announced the dosing of the first patient in a bridging study for ZYNLONTA in China, aiming to support regulatory submission in this key market....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including ADC Therapeutics, are just a search away.